人类转录模式的泛癌实验特征与端粒酶逆转录酶 (TERT) 相关的基因表达状态
Aleksey Drobyshev1,2, Alexander Modestov2, Maria Suntsova1,2
1Endocrinology Research Center, Moscow, Russia.
Frontiers in genetics
|June 11, 2024
概括
端粒酶逆转录酶 (TERT) 基因在许多癌症中被重新激活,影响DNA修复和细胞增殖. 它的表达模式揭示了不同的癌症亚型和治疗点.
科学领域:
- * 分子生物学 * 分子生物学
- * 癌症基因组学
- * 基因表达分析
背景情况:
- * TERT基因对端粒酶逆转录酶进行编码,对于端粒维护至关重要.
- * TERT通常在正常细胞中被抑制,但在癌症中被重新激活,这通常与预后不佳有关.
- *了解TERT表达模式对于癌症研究和治疗开发至关重要.
研究的目的:
- *为了研究TERT基因在各种人类癌症中的RNA测序表达模式.
- * 识别与TERT表达相关的基因,通路和分子机制.
- * 探索TERT表达,促进子突变和癌症生物学之间的关系.
主要方法:
- *分析了来自27种瘤类型的1039个人类癌症样本的RNA测序数据.
- * 检查TERT表达分布和与其他基因的相关性.
- * TERT阳性和TERT阴性癌症之间的分子谱的比较.
- *研究TERT促进子突变及其对表达的影响.
主要成果:
- *观察到TERT表达的双模分布,约27%的样本缺乏表达.
- * TERT表达与1443个基因相关,包括103个转录因子.
- *TERT阳性癌症显示过度激活的DNA修复 (84%的途径),复制,转录,翻译和细胞周期进展.
- *TERT阴性癌症表现出明显的细胞循环调节和表皮细胞到介质细胞的过渡途径.
- *在13%的TERT阳性癌症中发现了TERT促进子突变,但与更高的TERT表达没有相关性.
- *在TERT阳性癌症中观察到L1逆转移体表达的减少,在促进物突变的病例中进一步减少.
- * TERT表达与17个癌症治疗药物向的基因相关.
结论:
- * TERT表达是人类癌症中不同分子亚型的关键决定因素.
- *TERT阳性癌症的特征是增强的DNA修复和增殖过程.
- *除了促进子突变之外,并行机制有助于癌症中TERT转录激活.
- * TERT表达模式和相关的分子标可能会为差异性生存和治疗策略提供信息.
更多相关视频
相关概念视频
02:41Telomeres and Telomerase
23.3K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.3K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K